期刊文献+

血清基质金属蛋白酶9及其抑制物1与糖尿病视网膜病变的关系 被引量:4

Relationship between serum MMP-9 and TIMP-1 in the patients with diabetic retinopathy
暂未订购
导出
摘要 目的探讨血清基质金属蛋白酶-9(MMP-9)及其抑制物-1(TIMP-1)与糖尿病视网膜病变(DR)的关系。方法采用酶联免疫吸附法对2型糖尿病患者(DM组)及正常对照组(NC组)血清MMP-9、TIMP-1、Ⅳ型胶原(CIV)水平进行检测,并按眼底结果分为三组:未合并视网膜病变(NDR)组25例,单纯型视网膜病变(SDR)组32例,增殖型视网膜病变(PDR)组18例进行组间比较。结果DM血清TIMP-1、CIV的水平是升高的且随着DR病情程度进展及病程的延长愈加明显,而MMP-9及其MMP-9/TIMP-1比值呈相应递减趋势,MMP-9水平与UAER、FBG显著负相关,TIMP-1水平与UAER、血压呈正相关。结论MMP-9及TIMP-1参与DR发生发展,检测其血清水平可反映DR严重程度。 Objective to measure the serum MMP-9 ( metalloproteinase matrix -9) TIMP-1 ( tissue inhibitor of metalloproteinase-1 )CIV (type IV collagen ) levels to study the significance of them in the pathogenesis of diabetic retinopathy(DR) and the possible relationship among them in DR. Methods the levels of serum MMP-9 ,TIMP-1 and CIV were measured by ELISA in 20 normal controls( NC group)and 75 cases with type 2 DM( DM group)including 25 cases without diabetic retinopathy( NDR group)32 cases with simple diabetic retinopathy( SDR group)and 18 cas6s with proliferative diabetic retinopathy( PDR group). Results the level of TIMP-1 in PDR group was significantly higher than those in NDR and SDR groups(P 〈0. 001 ,P 〈0. 001 ) ,while the level of MMP-9 and the ratio of MMP-9/TIMP-1 in PDR group was significantly lower than those in SDR groups( P 〈 0.05 ). There were remarkably positive correlations between TIMP-1 and UAER,SBP,while there were significantly negative correlations between MMP-9 and UAER,FBG. Conclusions these results demonstrated that the increased serum TIMP-1 and decreased MMP-9 levels in diabetic patients seem to participate in the pathagenesis of DR and are related to the severity of DR lesion.
出处 《临床内科杂志》 CAS 2005年第9期592-594,共3页 Journal of Clinical Internal Medicine
关键词 基质金属蛋白酶 糖尿病视网膜病变 2型糖尿病 Metallproteinase matrix Diabetic retinopathy Diabetic mellitus
  • 相关文献

参考文献7

  • 1李晓玲,葛秀兰,苏胜偶.2型糖尿病肾病患者血清金属蛋白酶9及其组织抑制因子1水平变化的临床意义[J].中华内分泌代谢杂志,2003,19(1):52-53. 被引量:20
  • 2Das A,McGuire PG,Eriqat C,et al.Human diabetic neovascular membrance contain high levels of urokinase and metalloproteinase enzymes.Invest Ophthalmol Vis Sci, 1999, 40:809-813.
  • 3Uemura S,Matsushita H,Li W,et al.Diabetes Mellitus enhances vascular matrix metalloproteinase activith:role of oxidative stress.Cire Res,2001,88:1291-1298.
  • 4Moses M.The regulation of neovascularization by matrix metalloproteinases and their inhibitors.Stem Cell,1997,15:180-189.
  • 5Ebihara LJ,Nakamura T,Shimada N,et al.Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.Am J Kidney Dis,1998,32:669-671.
  • 6Joel Salzmann,G Astrid Limb,Peng T Khaw,et al.Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy.Br J Ophthalmol,2000,84:1091-1096.
  • 7Grant MB,Caballero S,Tarnuzzer RW,et al. Matrix metalloproteinases expression in human retinal microvascular cells.Diabetes, 1998,76:79-85.

二级参考文献3

  • 1Suzuki D;Miyazaki M;Jinde K.In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type Ⅳ collagen in diabetic nephropathy[J],1997(1).
  • 2Ebihara I;Nakamura T;Shimada N.Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus,1998.
  • 3Kanauchi M;Nishioka H;Nakashiam Y.Role of tissue inhibitors of metalloproteinase in diabetic nephropathy,1996(03).

共引文献19

同被引文献92

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部